Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic‐ischaemic encephalopathy
Referencias
Additional references
Arellano F, Sacristán JA. Allopurinol hypersensitivity syndrome: a review. Annals of Pharmacotherapy 1993;27:337‐43.
Clancy RR, McGaurn SA, Goin JE, Hirtz DG, Norwood WI, Gaynor JW, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001;108:61‐70.
Coghlan JG, Flitter WD, Clutton SM, Panda R, Daly R, Wright G, et al. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery 1994;107:248‐56.
Edwards AD, Azzopardi DV. Therapeutic hypothermia following perinatal asphyxia. Archives of Disease in Childhood 2006;91:F127‐31.
Evans DJ, Levene MI. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database of Systematic Reviews 2001, Issue 2.
Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia.. Cochrane Database of Systematic Reviews 2002, Issue 3.
Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Seminars in Neonatology 2000;5:3‐16.
Jacobs S, Hunt R, Tarnow‐Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2003, Issue 4.
Johnson WD, Kayser KL, Brenowitz JB, Saedi SF. A randomized controlled trial of allopurinol in coronary bypass surgery. American Heart Journal 1991;121:20‐4.
Kecskes Z, Healy G, Jensen A. Fluid restriction for term infants with hypoxic‐ischaemic encephalopathy following perinatal asphyxia. Cochrane Database of Systematic Reviews 2005, Issue 3.
Kumar A, Edward N, White MI, Johnston PW, Catto GR. Allopurinol, erythema multiforme, and renal insufficiency. BMJ 1996;312:173‐4.
MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319:1054‐59.
Marro PJ, Baumgart S, Delivoria‐Papadopoulos M, Zirin S, Corcoran L, McGaurn SP, et al. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatric Research 1997;41:513‐20.
McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2004, Issue 1.
Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacological Reviews 2006;58:87‐114.
Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic‐ischemic brain damage with allopurinol. Pediatric Research 1990;27:332‐6.
Palmer C, Smith MB, Williams GD. Allopurinol preserves cerebral energy metabolism during perinatal hypoxic‐ischemic injury and reduces brain damage in a dose dependent manner. Journal of Cerebral Blood Flow and Metabolism 1991;11:S144‐S149.
Palmer C, Towfighi J, Roberts RL, Heitjan DF. Allopurinol administered after inducing hypoxia‐ischemia reduces brain injury in 7‐day‐old rats. Pediatric Research 1993;33:405‐11.
Roth SC, Baudin J, Cady E, Johal K, Townsend JP, Wyatt JS, et al. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Developmental Medicine and Child Neurology 1997;39:718‐25.
Sarnat H, Sarnat M. Neonatal encephalopathy following fetal distress. Archives of Disease in Childhood 1976;33:696‐705.
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole‐body hypothermia for neonates with hypoxic‐ischemic encephalopathy. New England Journal of Medicine 2005;353:1574‐84.
Sisto T, Paajanen H, Metsa‐Ketela T, Harmoinen A, Nordback I, Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Annals of Thoracic Surgery 1995;59:1519‐23.
Van Bel F, Shadid M, Moison RM, Dorrepaal CA, Fontijn J, Monteiro L, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185‐93.
Vannucci RC. Current and potentially new management strategies for perinatal hypoxic‐ischemic encephalopathy. Pediatrics 1990;85:961‐8.
Vazquez‐Mellado J, Morales EM, Pacheco‐Tena C, Burgos‐Vargas R. Relation between adverse events associated with allopurinol and renal function in patients with gout. Annals of the Rheumatic Diseases 2001;60:981‐3.
Warner DS, Sheng H, Batinic‐Haberle I. Oxidants, antioxidants and the ischemic brain. Journal of Experimental Biology 2004;207:3221‐31.
